NCT04800107View on ClinicalTrials.gov

Effect of Highly Bioavailable Curcumin on Subjective Tinnitus

NAActive, not recruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

January 6, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Tinnitus, Subjective
Interventions
BIOLOGICAL

Curcumin-phosphatidylcholine

500 mg of curcumin-phosphatidylcholine combined with 250 mg of boswellia-phosphatidyl

BIOLOGICAL

Placebo capsule

Placebo capsule

Trial Locations (3)

48073

Michigan Ear Institute, Royal Oak

48334

Michigan Ear Institute, Farmington Hills

48374

Michigan Ear Institute, Novi

All Listed Sponsors
lead

Henry Ford Health System

OTHER